Current Rating and Its Significance
The current Buy rating for Artemis Medicare Services Ltd indicates a positive outlook based on a comprehensive evaluation of multiple factors. This rating suggests that the stock is expected to deliver favourable returns relative to its peers and the broader market, making it an attractive option for investors seeking growth opportunities in the hospital sector. The rating was revised from a previous Hold status, reflecting improved confidence in the company’s prospects.
Here’s How Artemis Medicare Services Ltd Looks Today
As of 03 January 2026, Artemis Medicare Services Ltd holds a Mojo Score of 70.0, which corresponds to a Buy grade. This score is a composite measure derived from quality, valuation, financial trend, and technical analysis, providing a holistic view of the stock’s investment potential.
Quality Assessment
The company’s quality grade is assessed as average. This reflects a stable operational foundation with consistent profitability and manageable debt levels. Artemis Medicare Services Ltd demonstrates a strong ability to service its debt, with a Debt to EBITDA ratio of just 1.34 times, indicating prudent financial management and limited leverage risk. Additionally, the company has maintained positive results for seven consecutive quarters, underscoring operational resilience.
Valuation Perspective
Currently, the company’s valuation is considered attractive. The stock trades at a Price to Book Value of 5, which, while seemingly high, is justified by its robust return on equity (ROE) of 10.8%. Moreover, the stock is trading at a discount relative to its peers’ historical valuations, offering investors a favourable entry point. Despite a 13.39% negative return over the past year, the company’s profits have grown by 46.9%, resulting in a PEG ratio of 1.7, which suggests that the stock’s price reasonably reflects its earnings growth potential.
Register here to know the latest call on Artemis Medicare Services Ltd
- - Fundamental Analysis
- - Technical Signals
- - Peer Comparison
Financial Trend
The financial trend for Artemis Medicare Services Ltd is very positive. The company has exhibited strong long-term growth, with operating profit increasing at an annual rate of 82.15%. Net profit growth stands at 41.51%, reflecting efficient cost management and expanding margins. The operating cash flow for the year reached a peak of ₹139.08 crores, while the return on capital employed (ROCE) for the half-year was a healthy 13.34%. Furthermore, the debt-equity ratio remains low at 0.32 times, reinforcing the company’s conservative capital structure and financial stability.
Technical Outlook
From a technical standpoint, the stock is rated as mildly bullish. Recent price movements show moderate upward momentum, with a 3-month return of 18.81% and a 6-month return of 11.00%. The stock’s one-month gain of 1.81% and year-to-date increase of 2.92% further support this positive technical sentiment. Although the one-day change was a slight decline of 0.36%, the overall trend remains constructive, signalling potential for further appreciation.
Stock Returns and Market Context
As of 03 January 2026, Artemis Medicare Services Ltd has delivered mixed returns. While the one-year return is negative at -13.39%, this contrasts with the company’s strong profit growth, indicating that the market may not have fully priced in the improving fundamentals. Shorter-term returns are more encouraging, with gains of 18.81% over three months and 11.00% over six months, suggesting growing investor confidence. This divergence between earnings growth and stock price performance may present an opportunity for investors seeking value in the hospital sector.
Perfect timing to enter! This Small Cap from IT - Software just turned profitable with growth momentum clearly building up. Get in before the broader market notices!
- - New profitability achieved
- - Growth momentum building
- - Under-the-radar entry
What This Rating Means for Investors
For investors, the Buy rating on Artemis Medicare Services Ltd signals a recommendation to consider accumulating shares based on the company’s solid fundamentals and growth prospects. The attractive valuation combined with strong financial trends suggests that the stock is well-positioned to benefit from the expanding healthcare sector. The mildly bullish technical indicators add further confidence that the stock price may continue to appreciate in the near term.
Investors should note that while the stock has experienced some volatility and a negative return over the past year, the underlying earnings growth and cash flow generation provide a strong foundation for future gains. The company’s prudent debt management and consistent profitability reinforce its resilience in a competitive market environment.
Overall, the MarketsMOJO Buy rating reflects a balanced view that considers both the opportunities and risks associated with Artemis Medicare Services Ltd, making it a compelling choice for investors seeking exposure to the hospital sector’s growth trajectory.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year (MRP = Rs. 34,999) Start Saving Now →
